📈 Jumpstart Signal Watchlist — June 04, 2026

🏢 What they do: A10 Networks is an American public company specializing in application delivery controllers and cybersecurity solutions for on-premises, cloud, and edge environments. The company provides software and hardware products that secure applications, networks, and infrastructure from cyber threats while optimizing performance and availability across hybrid cloud architectures.
- 🎯 Current $31.70 is 3% below 3yr high $32.64 · ⏳ SMA200 $20.46 (current price $31.70 is above) · 💰 Market Cap $2.3B
- ATEN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 55/60
- 🏦 Low drawdown (9.5% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 31% (>20%); ROE 20% (>15%); Low LT D/E 0.99 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (8.0%)
- 🔔 Strong above EMA50 (17.0%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 70 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ A10 Networks stock hits all-time high at 30.09 USD — Investing.com UK.
🤖 This article is positive because it says A10 Networks reached an all-time high after reporting revenue of $75 million, up 13.4% year over year, and beating analyst expectations. Strong top-line growth and a price breakout are favorable signals for the stock.
✅ AlphaQuest LLC Grows Position in A10 Networks, Inc. $ATEN — MarketBeat.
🤖 This is mildly positive because it highlights A10 Networks’ FY2026 EPS guidance of $0.640-$0.650, a quarterly dividend of $0.06 per share, and continued analyst support with a Moderate Buy consensus. The article is framed around institutional buying interest and generally constructive fundamentals.
✅ A10 Networks, Inc. $ATEN Stock Position Decreased by Hillsdale Investment Management Inc. — MarketBeat.
🤖 Despite the headline about a stake reduction, the article emphasizes A10 Networks’ earnings beat, 13.4% revenue growth, and strong profitability metrics such as a 25.00% return on equity. Those operating results are supportive for the stock, making the overall tone positive.
🍭 Bonus (B): 10/10 — Computer Communications Equipment (Technology sector)

🏢 What they do: Exelixis is an oncology-focused biotechnology company that discovers, develops, and commercializes medicines for hard-to-treat cancers. Its main products include CABOMETYX (cabozantinib), COMETRIQ (cabozantinib), and COTELLIC (cobimetinib), and it also advances a pipeline of small molecules and biotherapeutics for cancer treatment.
- 🎯 At/above 3yr high $52.49 (current $52.49) · ⏳ SMA200 $42.76 (current price $52.49 is above) · 💰 Market Cap $13.3B
- EXEL shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 Low drawdown (12.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 44% (>20%); ROE 43% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (6.0%)
- 🔔 Strong above EMA50 (10.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive.
✅ Marietta Investment Partners LLC Has $815,000 Stock Holdings in Exelixis, Inc. — MarketBeat.
🤖 This article is mildly positive because it notes EXEL rose 6.3% and highlights that TD Cowen raised its price target to $55. The piece also frames the stock as supported by institutional interest, though it still describes consensus as Hold.
✅ LSV Asset Management Sells 22,695 Shares of Exelixis, Inc. $EXEL — MarketBeat.
🤖 The article is positive overall because it says Exelixis reported better-than-expected quarterly earnings, with EPS of $0.87 versus the $0.75 estimate and revenue up 10% year over year. The headline itself is about an investor sale, but the underlying company update points to strong results.
⚪️ Exelixis, Inc. $EXEL Shares Purchased by BNP Paribas Financial Markets — MarketBeat.
🤖 This is mostly neutral because it is a holdings/ownership update rather than a major operational catalyst. The article mentions the stock was trading down 3.5%, but it does not report new company fundamentals or a clear business development.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

🏢 What they do: Adeia Inc. is a technology company that invents, develops, and licenses innovations and intellectual property solutions for the entertainment, media, consumer electronics, and semiconductor industries. Its primary focus includes licensing technologies for Pay-TV, connected car systems, media platforms, and related consumer products.
- 🎯 Current $32.36 is 4% below 3yr high $33.63 · ⏳ SMA200 $19.77 (current price $32.36 is above) · 💰 Market Cap $3.6B
- ADEA passed all filters and shows favorable conditions.

💎 Quality (Q): 52/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 100% (>20%); Revenue growth 20% (>15%); ROE 26% (>15%); Low LT D/E 0.84 (<1.0).
⏰ Entry (E): 9/20
- 🔔 Strong above EMA21 (10.9%)
- 🔔 Strong above EMA50 (16.5%)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 5/10
- 🗞️ No recent news coverage available.
🍭 Bonus (B): 0/10 — Cable & Other Pay TV

🏢 What they do: Constellium SE designs and manufactures specialty rolled and extruded aluminum products for the aerospace, packaging, and automotive industries. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry, serving blue-chip customers with performance-critical applications.
- 🎯 At/above 3yr high $36.15 (current $36.15) · ⏳ SMA200 $21.93 (current price $36.15 is above) · 💰 Market Cap $4.9B
- CSTM shows decent technicals supported by positive sentiment.

💎 Quality (Q): 52/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 446% (>20%); Revenue growth 24% (>15%); ROE 39% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.2%)
- 🔔 Strong above EMA50 (15.4%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive.
✅ What Makes Constellium (CSTM) a Strong Momentum Stock: Buy Now? — Zacks Equity Research.
🤖 Zacks highlights Constellium as a strong momentum stock, citing a Zacks Rank of #1 (Strong Buy) and a Momentum Score of A. That type of bullish quantitative rating is generally supportive for the stock price.
🍭 Bonus (B): 0/10 — Primary Metal Industries

🏢 What they do: Amkor Technology, Inc. (AMKR) is the world's largest U.S.-headquartered outsourced semiconductor assembly and test (OSAT) provider, specializing in semiconductor packaging and test services.
- 🎯 Current $73.82 is 6% below 3yr high $78.10 · ⏳ SMA200 $45.10 (current price $73.82 is above) · 💰 Market Cap $18.3B
- AMKR passed all filters and shows favorable conditions.

💎 Quality (Q): 36/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 267% (>20%); Revenue growth 27% (>15%); Low LT D/E 0.25 (<1.0).
⏰ Entry (E): 4/20
- 🔔 Strong above EMA50 (11.9%)
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral.
⚪️ UBS Group AG Buys 843,983 Shares of Amkor Technology, Inc. ... — MarketBeat.
🤖 This is a routine holdings update about UBS increasing its position in AMKR, with no operating results, guidance change, or company-specific catalyst disclosed. The article also references an unchanged consensus 'Hold' view and target price, which makes it broadly neutral for the stock.
⚪️ Financial Group Inc. Sells 69725 Shares of Amkor Technology, Inc. ... — MarketBeat.
🤖 This is another ownership-filing update showing Principal Financial Group reduced its AMKR stake. It does not report new fundamentals or a company event, so the likely stock impact is neutral.
🍭 Bonus (B): 10/10 — Semiconductors (Technology sector)